Thomas Van den Broeck
Papers
5
Total Citations
124
H-Index
4
About
Thomas Van den Broeck is a leading urologic oncologist whose research centers on optimizing surgical and ablative treatments for prostate cancer, particularly for high-risk and recurrent disease. His most impactful work, a 2021 systematic review on focal ablative therapy (52 citations), critically evaluated the evidence for this emerging approach against standard management, providing essential guidance for clinical practice and future research. Van den Broeck has made significant contributions to the surgical management of aggressive prostate cancer, notably through his 2013 review on surgery for high-risk disease (28 citations), which helped clarify the role of radical prostatectomy in this challenging patient population. He has also advanced understanding of lymph node dissection, authoring a key systematic review on the benefits and harms of different extents of dissection during radical prostatectomy (28 citations) and pioneering comparative studies on robot-assisted versus open salvage lymph node dissection for recurrent cancer. His recent work on salvage vesiculectomy for local recurrence demonstrates his ongoing commitment to developing innovative surgical techniques. With over 120 total citations, Van den Broeck’s research directly shapes evidence-based urologic oncology, balancing oncologic control with quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2Results of surgery for high-risk prostate cancer28 citations · 2013
- 3
- 4
- 5